腫瘍形成における乳化とRNA変異の交響:メカニズムと治療的影響
PubMedで要約を見る
まとめ
この要約は機械生成です。ラクチレーションは翻訳後の改変 (PTM) で,がんにおけるRNA改変と相互作用する. このクロストークを理解することで 精密標的がん治療の 新しい治療戦略が生まれます
科学分野
- 生物化学
- 分子生物学
- 癌 研究
背景
- 新興のエビデンスは,トランスレーション後の修正 (PTM) と腫瘍の進行を関連付けています.
- 乳化とRNA変異の相互作用は,疾患の病原性において十分に理解されていません.
- 癌の生物学を発展させるには これらの分子交響の調査が不可欠です
研究 の 目的
- ラクチレーションとRNAの改変の間の規制相互作用に関する現在の知識をレビューする.
- 癌におけるこのクロストークの 機能的影響を探求するためです
- がん治療におけるこれらの改変を標的とした治療の可能性を議論する.
主な方法
- 乳化とRNAの改変に関する既存の研究の文献レビュー.
- 癌生物学におけるメカニズム的関与の分析
- 治療戦略に関する情報の合成
主要な成果
- 乳化とRNAの改変は,がんの進行に影響を与える複雑なクロストラックを示します.
- このクロストークを媒介する特定のメカニズムが解明され始めています.
- これらの改変をターゲットにすることで 新しいがん治療の可能性が生まれます
結論
- 乳化とRNAの改変の交響は癌において重要な役割を果たす.
- これらの相互作用に関するさらなる研究により,新たな治療目標が明らかになる可能性があります.
- 組み合わせた標的化戦略は,がん治療の精度を高めることができます.
関連する概念動画
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
Intact DNA strands can be found in fossils, while scientists sometimes struggle to keep RNA intact under laboratory conditions. The structural variations between RNA and DNA underlie the differences in their stability and longevity. Because DNA is double-stranded, it is inherently more stable. The single-stranded structure of RNA is less stable but also more flexible and can form weak internal bonds. Additionally, most RNAs in the cell are relatively short, while DNA can be up to 250 million...
The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the...
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

